Who owns ASPIRE BIOPHARMA HLDGS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Aspire Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aspire Biopharma Hldgs stock

Who bought or sold ASPIRE BIOPHARMA HLDGS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Crewe Advisors 813k $168k 30% Sep 2025
 View chart
Procyon Private Wealth Partners 473k $97k -27% Sep 2025
 View chart
Vanguard Group 429k $88k 100% Sep 2025
 View chart
Optivise Advisory Services 264k $54k 12% Sep 2025
 View chart
Geode Capital Management 250k $52k 100% Sep 2025
 View chart
Antara Capital 203k $42M 100% Sep 2025
 View chart
VR Advisory Services 97k $20k 0% Sep 2025
 View chart
Resolute Advisors 83k $17k 100% Sep 2025
 View chart
Three Seasons Wealth 75k $16k 0% Sep 2025
 View chart
P. Schoenfeld Asset Management 59k $12k 100% Sep 2025
 View chart
Efficient Wealth Management 54k $11k 100% Sep 2025
 View chart
Periscope Capital 50k $10k -33% Sep 2025
 View chart
Atlantic Trust 49k $10k 591% Sep 2025
 View chart
Hallmark Capital Management 40k $8.2k 0% Sep 2025
 View chart
Platform Technology Partners 38k $7.7k 0% Sep 2025
 View chart
Tower Research Capital 31k $6.4k 100% Sep 2025
 View chart
Jane Street 29k $6.0k -81% Sep 2025
 View chart
XTX Topco 28k $5.7k 100% Sep 2025
 View chart
Crossingbridge Advisors 24k $7.4k 100% Sep 2025
 View chart
Colony 13k $2.6k 100% Sep 2025
 View chart
Allred Capital Management 11k $2.3k 0% Sep 2025
 View chart
UBS Group 7.7k $1.6k 100% Sep 2025
 View chart
SOA Wealth Advisors 2.9k $602.104000 100% Sep 2025
 View chart
Advisor Group Holdings 100.00 $20.000000 0% Sep 2025
 View chart

Who sold out of Aspire Biopharma Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
Scientech Research Jun 2025 17k $4.4k
Raymond James Financial Jun 2025 2.5k $673.000000